No Data
Gelonghui Announcement Summary (Hong Kong Stocks) | GOLDLION HOLD (00533.HK) is being privatized by Chairman Zeng Zhiming at a premium of approximately 24.85%. Trading will resume tomorrow.
【Today's Focus】GOLDLION HOLD (00533.HK) is being privatized by chairman Zeng Zhiming at a premium of about 24.85%. Trading will resume tomorrow. GOLDLION HOLD (00533.HK) announced that on December 2, 2024, the offeror, Guanglang Limited, requests the Board of Directors to present a proposal to the planned Shareholders to privatize the company by means of a scheme arrangement according to Section 673 of the Companies Ordinance. Under the plan, the cancellation price for each Scheme Share to be canceled and removed is Cash 1.5232 HKD, which is a premium of approximately 24% over the closing price of HKD 1.22 per share reported on the last trading day of November 21, 2024 on the Stock Exchange.
LEPU ScienTech Medical Gets Registration Certificate for Transcatheter Aortic Valve Replacement System in China
Xintai Medical (02291.HK): ScienCrown transcatheter implanted aortic valve system has obtained the medical instruments registration certificate.
On December 17, Gelonghui reported that Xin Tai Medical (02291.HK) announced that the National Medical Products Administration of China has issued the medical instruments registration certificate for the ScienCrown transcatheter aortic valve system (with Lepu (Peking) Medical Devices Co., Ltd. as the medical instruments registrant). The structural design of the ScienCrown transcatheter aortic valve system is based on clinical practices and effectively addresses existing issues such as poor valve expansion, inaccurate positioning, displacement risks, and coronary artery obstruction during the TAVR procedure.
Express News | Lepu Scientech Medical Technology Shanghai - Medical Device Registration Certificate for Sciencrown Tavr System Granted by Nmpa
LEPU ScienTech Gains Shareholder Approval for Key Resolutions
LEPU ScienTech Medical Technology Reveals Board Restructure
